Cargando…
Nanobiomaterials in cancer therapy : applications of nanobiomaterials /
Nanobiomaterials in Cancer Therapy presents the major applications of nanobiomaterials in oncology, offering an up-to-date overview of the latest research in this field. Utilizing nanobiomaterials, novel therapeutic approaches enable significant improvements in drug-loading capacity, formulation sta...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford :
William Andrew, an imprint of Elsevier,
2016.
|
| Colección: | Applications of nanobiomaterials ;
volume 7 |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover; Nanobiomaterials in Cancer Therapy; Copyright Page; Contents; List of contributors; Preface of the series; Preface; About the Series (Volumes I-XI); About Volume VII; 1 Nanopreparations for skin cancer therapy; 1.1 Introduction; 1.2 Skin Morphology; 1.3 Types of Cancer; 1.4 Non-Melanoma Skin Cancer; 1.5 Melanoma Skin Cancer; 1.6 Penetration Pathways of Skin; 1.7 Drug Delivery Systems Applied to Skin Cancer Treatment; 1.8 Liposomes; 1.9 Nanoemulsions and Nanosuspensions; 1.10 Polymeric Nanoparticles; 1.11 Lipid Nanoparticles; 1.12 Dendrimers; 1.13 Photodynamic Therapy
- 1.14 ConclusionsReferences; 2 Silver nanoparticles in cancer therapy; 2.1 Introduction; 2.2 Silver Nanoparticles; 2.3 Synthesis; 2.3.1 Chemical Synthesis; 2.3.2 Physical Synthesis; 2.3.3 Biological Synthesis; 2.3.3.1 Silver nanoparticles synthesized by bacteria; 2.3.3.2 Silver nanoparticles synthesized by fungi; 2.3.3.3 Silver nanoparticles synthesized by plants; 2.4 Shape; 2.5 Silver Nanoparticles-Cancer Diagnosis and Treatment Applications; 2.5.1 Leukemia; 2.5.2 Breast Cancer; 2.5.3 Lung Cancer; 2.5.4 Prostate Cancer; 2.5.5 Hepatic Cancer; 2.5.6 Cervical Cancer; 2.5.7 Skin Cancer
- 2.5.8 Larynx Cancer2.5.9 Colon Cancer; 2.6 Conclusions; References; 3 Nanobiomaterials in cancer therapy; 3.1 Introduction; 3.2 The Enhanced Permeability and Retention (EPR) Effect; 3.3 Nanomaterials in Cancer Therapy; 3.3.1 Inorganic NPs; 3.3.1.1 Quantum dots; 3.3.1.2 Magnetic NPs; 3.3.2 Organic NPs; 3.3.2.1 Liposomes; 3.3.2.2 Polymeric micelles; 3.3.2.3 Dendrimers; 3.4 Chemotherapy-Based Nanoformulations; 3.4.1 Doxorubicin; 3.4.2 Paclitaxel; 3.4.3 Cisplatin; 3.4.4 Docetaxel; 3.4.5 Nanotetrac; 3.5 Multifunctional NPs; 3.5.1 Delivery of siRNA and shRNA Complexes; 3.5.2 Active Targeting
- 3.6 Cancer Therapy Using Natural Products: Nanochemoprevention3.6.1 EGCG; 3.6.2 Resveratrol; 3.6.3 Curcumin; 3.7 Cancer Stem Cells: A Nanotechnology Perspective; 3.8 Conclusions; References; 4 Advances in nanobiomaterials for oncology nanomedicine; 4.1 Introduction; 4.2 Organic Nanobiomaterials; 4.2.1 Liposomes; 4.2.2 Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC); 4.2.3 Polymeric Nanocapsules and Nanospheres; 4.3 Inorganic Nanobiomaterials; 4.3.1 Mesoporous Silica Nanoparticles (MSNs); 4.3.2 Spherical Nucleic Acid Nanoparticles (SNA-NPs)
- 4.3.3 Boron Nitride Nanotubes (BNNTs)4.4 Combination of Nanotechnology with Photodynamic Therapy to Improve Cancer Treatment; 4.5 Toxicity and Risk Management; 4.6 Conclusions; Acknowledgments; References; 5 Nanobiomaterials: Emerging platform in cancer theranostics; 5.1 Introduction; 5.2 Theranostics and Nanomedicine; 5.2.1 Gold Nanoparticles; 5.2.2 Iron Oxide Nanoparticles in Cancer Theranostics; 5.2.3 Superparamagnetic Iron Oxide Nanoparticles; 5.2.4 Carbon Nanotubes; 5.2.5 Quantum Dots; 5.2.6 Dendrimers; 5.2.7 Vesicular Systems; 5.2.7.1 Liposomes; 5.2.7.2 Polymerosomes